Navigation Links
A Vitamin A Day May Delay The Life span Of HIV Patients

A vitamin a day could slow down the progression of HIV, according to new research. Researchers say this could be a low-cost way to delay the progression of this deadly disease. Past studies have indicated that // multivitamins may play a role in the progression of HIV. However researchers recently conducted a study to determine if vitamins have an impact on the disease.

The study included 1,078 pregnant women who were infected with HIV. The women were given daily supplements of vitamin A, a multivitamin, both vitamin A and a multivitamin, or a placebo. The women were followed for nearly six years.

Researchers report just 67 of the 271 women on a multivitamin progressed to stage 4 of the disease or died. In comparison, 83 of the 267 women on placebo progressed to stage 4 or died. The women on the multivitamin also had lower viral loads. However, the effects of receiving vitamin A alone were not much different than those of placebo. Plus, adding vitamin A to the multivitamin seemed to reduce some of the benefits.

Thus researchers conclude that a daily multivitamin supplement may be a cost-effective way to delay the progression of HIV in infected women. However, they say further research is needed to look at the use of vitamin A in patients with this disease.
'"/>




Page: 1

Related medicine news :

1. Vitamin B12 can help in detecting cancers
2. Vitamins-The answer to Heart Disease?
3. Vitamin E, the latest warrior against diabetes
4. Vitamin Shields Brittle Bones
5. B Vitamin protects and lowers toxicity of Arthritis Drug
6. B Vitamin Supplementatoin Saves Money and Lives
7. Eat Vitamin C and stay young
8. Vitamin C for the heart
9. Vitamin B for Hepatitis
10. Vitamins reduce pre-eclampsia
11. Vitamin E useful for Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Vitamin Day May Delay The Life span HIV Patients

(Date:9/4/2015)... ... ... consumers are looking for a quick and convenient way to produce a hot remedy for ... provide a quick and simple way to brew a hot cup of cold remedy when ... result, they enhance comfort and health. The invention features a novel design that is lightweight, ...
(Date:9/4/2015)... Washington (PRWEB) , ... September 04, 2015 , ... ... design and development of its first neighborhood created specifically for adults with intellectual, ... in the Phoenix Metro area and feature 30 cottage or “pocket” homes. In ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... a Labor Day offer that cannot be passed up. FiltersFast.com, will ship ... necessary air and water filtration product replacements. Take advantage of this promotion now ...
(Date:9/3/2015)... Fullerton, Calif. (PRWEB) , ... September 03, 2015 , ... ... in Fullerton, where innovative medicine is the norm not the exception. , St. Jude ... and the American Heart Association/American Stroke Association, making it one of only 10 hospitals ...
(Date:9/3/2015)... ... 03, 2015 , ... E-Volve Health, an Elliot Health System ... organization, to provide electronic medical record (EMR) consulting services to Amerinet clients running ... negotiated pricing on E-Volve Health’s Epic EMR consulting, custom training and support services. ...
Breaking Medicine News(10 mins):Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2
... company PreMD Inc. (TSX: PMD; PREMF.pk) today announced the ... Corporation. Mr. Davis has been a director of PreMD ... sincere thanks to Paul for his contribution to PreMD," ... Inc.PreMD Inc. has rapid, non-invasive tests for the early ...
... drugs could prevent 2 of 10 deaths expected in ... 26 (HealthDay News) -- Blood pressure-lowering drugs should be ... them from major cardiovascular events and death, say researchers ... Those studies assessed the effects of lowering blood pressure ...
... , Montreal, February 26, 2009 A team ... and its affiliated Maisonneuve-Rosemont Hospital Research Centre will be honoured ... prestigious award in the field of hip surgery. The award ... , As North American pioneers in the development of new ...
... that has discovered a new gene whose mutations cause ... sclerosis) is part of a national study led by ... study reported in Science today (Feb. 27) ... neurological disorder, said Teepu Siddique, M.D., Les Turner ALS ...
... 96% In First Full Year As A Public CompanyCARLSBAD, ... GXDX ), a specialized laboratory services provider, today reported ... 2008, which includes a $2.2 million benefit from changes ... is an increase of approximately 83.0% over revenues of ...
... fall and winter infants more likely to develop asthma ... high levels of pollen and mold in their first few ... a possible early symptom of asthma, say U.S. researchers. , ... California,s Salinas Valley, and found that children born in high ...
Cached Medicine News:Health News:PreMD Announces Resignation of Director 2Health News:Lowering BP in Dialysis Cases Cuts Heart Risks 2Health News:Team of orthopedic surgeons and kinesiologists win hippest of awards 2Health News:Researchers identify ALS gene mutation 2Health News:Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009 2Health News:Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009 3Health News:Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009 4Health News:Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009 5Health News:Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009 6Health News:Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009 7Health News:Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009 8Health News:Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009 9Health News:Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009 10Health News:Babies Born in High Pollen Months at Wheezing Risk 2
(Date:9/4/2015)... 4, 2015  PTC Therapeutics, Inc. (NASDAQ: ... of its first-ever global awards program, the STRIVE ... designed to aid nonprofit organizations that are committed ... The announcement is made as the global DMD ... Day on Monday, September 7, 2015. ...
(Date:9/4/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... Rodman & Renshaw 17 th Annual Global Investment ... New York City .  Dr. Michael Berelowitz ... on September 9, 2015. Presentation Details: ...
(Date:9/4/2015)... , September 4, 2015 Future ... Allergic Rhinitis drugs - new ... Where is the market for allergic rhinitis drugs ... Visiongain ,s new report shows you potential revenues ... prospects. Our 326 page report provides 273 ...
Breaking Medicine Technology:PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 3PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 4Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7
... Promising Clinical Activity in Patients with ... Difficult-to-Treat Cancers -, ... (Nasdaq: SNSS ) presented data from three clinical,trials of ... Foundation Symposium held in New York on November 4-8.,Data previously ...
... Inc.,(Nasdaq: MEDX ) today announced that it ... from its licensing partner, Centocor R&D Inc., for,the ... 95, a fully human antibody,targeting the integrin receptors ... human antibody was generated using Medarex,s,UltiMAb(R) technology. Medarex ...
Cached Medicine Technology:Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 2Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 3Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 4Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 5Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors 2
VACUETTE Trace Element tubes - Ridged (safety screw cap) are designed to test trace elements such as Cu, Zn, Pb, etc....
Inquire...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Inquire...
Medicine Products: